Relay Therapeutics (RLAY) Non Operating Income (2020 - 2025)
Relay Therapeutics' (RLAY) quarterly Non Operating Income came in at $30000.0 in Q4 2025, up 2900.0% year-on-year from $1000.0 in Q4 2024, and up 118.18% on a QoQ basis from -$165000.0 in Q3 2025.
Relay Therapeutics (RLAY) Non Operating Income (2020 - 2025) Analysis & Trends
Relay Therapeutics (RLAY) has 6 years of Non Operating Income data on file, last reported at $30000.0 in Q4 2025.
- On a quarterly basis, Non Operating Income rose 2900.0% year-over-year to $30000.0 in Q4 2025; TTM through Dec 2025 was -$777000.0, a 5650.0% decrease from a year earlier, with the FY2025 full-year figure at -$776000.0, down 5642.86% from the prior year.
- Non Operating Income for Q4 2025 stood at $30000.0, up from -$165000.0 in the prior quarter.
- Over the last five years, Non Operating Income for RLAY reached as high as $30000.0 in Q4 2025 and fell as low as -$633000.0 in Q2 2025.
- Historically, Non Operating Income has averaged -$44722.2 across 5 years, with a median of -$2500.0 in 2023.
- On a YoY basis, Non Operating Income climbed as much as 2900.0% in 2025 and fell as far as 31550.0% in 2025.
- Year by year, Non Operating Income stood at $1000.0 in 2021, then sank by 2500.0% to -$24000.0 in 2022, then jumped by 104.17% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then surged by 2900.0% to $30000.0 in 2025.
- Per Business Quant data, the three most recent Non Operating Income figures were $30000.0 in Q4 2025, -$165000.0 in Q3 2025, and -$633000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Relay Therapeutics | 3.31 Bn | 3.31 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | -165,000.00 |
| Jun 30, 2025 | -633,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -14,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Dec 31, 2022 | -24,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 18,000.00 |
| Mar 31, 2022 | -21,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | -5,000.00 |
| Dec 31, 2020 | -8,000.00 |
| Sep 30, 2020 | -5,000.00 |